Related Experiment Videos
Congestive heart failure clinical outcomes study in a private community medical group
1Preferred Primary Care Physicians, Pittsburgh, PA 15220, USA.
Insights
Implementing a congestive heart failure guideline improved angiotensin-converting enzyme (ACE) inhibitor use and reduced hospital admissions for systolic dysfunction. This quality improvement program enhanced patient care in primary care settings.
Area of Science:
- Cardiology
- Internal Medicine
- Healthcare Quality Improvement
Background:
- Angiotensin-converting enzyme (ACE) inhibitor therapy is underutilized in treating systolic dysfunction in congestive heart failure.
- Physicians often prescribe inadequate dosages of ACE inhibitors for heart failure patients.
- A need exists to improve the management of heart failure patients with systolic dysfunction.
Purpose of the Study:
- To evaluate the impact of integrating a clinical guideline into a continuous quality improvement (CQI) program.
- To assess improvements in care for patients with congestive heart failure (CHF) and systolic dysfunction.
Main Methods:
- Prospective study of CHF patients over 21 months in a private community medical group.
- Implementation of an internally developed CHF practice guideline, reinforced through computer access and monthly CQI meetings.
- Quarterly review of physician performance data.
Main Results:
- Significant improvement in the use of ACE inhibitor therapy at discharge for patients with systolic dysfunction.
- A 49% decline in quarterly hospital admissions for patients with systolic dysfunction.
- No change observed in the classification rates of systolic versus diastolic dysfunction or in the documentation of discharge instructions.
Conclusions:
- A disease management guideline, coupled with physician education and peer performance feedback, significantly enhanced the quality and efficiency of CHF care.
- The intervention proved effective in an independent primary care medical group setting.
- Continuous quality improvement initiatives can successfully address underuse of evidence-based therapies in chronic disease management.
Background:
Although angiotensin-converting enzyme (ACE) inhibitor therapy has been shown to improve clinical outcomes of patients with systolic dysfunction, it has been underused or prescribed in inadequate dosages by physicians in the treatment of congestive heart failure. Our goal was to evaluate whether integration of a clinical guideline within a continuous quality improvement program would improve care for patients with congestive heart failure caused by systolic dysfunction.
Methods:
All patients of a private community medical group who were admitted to the hospital with congestive heart failure were studied prospectively for 21 months. An internally developed congestive heart failure practice guideline was presented to the group's physicians. The guidelines were available in the hospital computer system and were reinforced at monthly quality improvement meetings. Performance data were reviewed quarterly with the physicians.
Results:
Rates of classifying systolic vs diastolic dysfunction remained unchanged during the study. Use of ACE inhibitor therapy at the time of discharge improved substantially for patients with systolic dysfunction. Quarterly admissions of patients with systolic dysfunction declined 49% throughout the study period. No improvement was noted in the documentation of specific discharge instructions.
Conclusions:
Use of a disease management guideline, ongoing physician education, and feedback of peer performance data to physicians significantly improved the quality and efficiency of care provided to patients with congestive heart failure in an independent, primary care medical group.